110 related articles for article (PubMed ID: 11410514)
21. A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients.
Wárlám-Rodenhuis CC; Koot VC; van der Luijt RB; Vasen HF; Ausems MG
Eur J Cancer; 2005 Jul; 41(10):1409-15. PubMed ID: 15955690
[TBL] [Abstract][Full Text] [Related]
22. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
[TBL] [Abstract][Full Text] [Related]
23. Application of multiplex PCR with histopathologic features for detection of familial breast cancer in formalin-fixed, paraffin-embedded histologic specimens.
Rassi H; Houshmand M; Hashemi M; Majidzadeh K; Akbari MH; Panahi MS
Tsitol Genet; 2008; 42(2):55-62. PubMed ID: 18630122
[TBL] [Abstract][Full Text] [Related]
24. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.
Li WF; Hu Z; Rao NY; Song CG; Zhang B; Cao MZ; Su FX; Wang YS; He PQ; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Liu XY; Zhou J; Wang L; Zhao L; Liu YB; Yuan WT; Yang L; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2008 Jul; 110(1):99-109. PubMed ID: 17851763
[TBL] [Abstract][Full Text] [Related]
25. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Jernström H; Lubinski J; Lynch HT; Ghadirian P; Neuhausen S; Isaacs C; Weber BL; Horsman D; Rosen B; Foulkes WD; Friedman E; Gershoni-Baruch R; Ainsworth P; Daly M; Garber J; Olsson H; Sun P; Narod SA
J Natl Cancer Inst; 2004 Jul; 96(14):1094-8. PubMed ID: 15265971
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil.
Gomes MC; Costa MM; Borojevic R; Monteiro AN; Vieira R; Koifman S; Koifman RJ; Li S; Royer R; Zhang S; Narod SA
Breast Cancer Res Treat; 2007 Jul; 103(3):349-53. PubMed ID: 17063270
[TBL] [Abstract][Full Text] [Related]
27. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
[TBL] [Abstract][Full Text] [Related]
28. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
29. Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Kotsopoulos J; Lubinski J; Lynch HT; Neuhausen SL; Ghadirian P; Isaacs C; Weber B; Kim-Sing C; Foulkes WD; Gershoni-Baruch R; Ainsworth P; Friedman E; Daly M; Garber JE; Karlan B; Olopade OI; Tung N; Saal HM; Eisen A; Osborne M; Olsson H; Gilchrist D; Sun P; Narod SA
Cancer Causes Control; 2005 Aug; 16(6):667-74. PubMed ID: 16049805
[TBL] [Abstract][Full Text] [Related]
30. Tissue-based predictors of germ-line BRCA1 mutations: implications for triaging of genetic testing.
de la Cruz J; Andre F; Harrell RK; Bassett RL; Arun B; Mathieu MC; Delaloge S; Gilcrease MZ
Hum Pathol; 2012 Nov; 43(11):1932-9. PubMed ID: 22591913
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations.
Martínez-Ferrandis JI; Vega A; Chirivella I; Marín-García P; Insa A; Lluch A; Carracedo A; Chaves FJ; García-Conde J; Cervantes A; Armengod ME
Hum Mutat; 2003 Nov; 22(5):417-8. PubMed ID: 14517958
[TBL] [Abstract][Full Text] [Related]
32. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
Jernström H; Loman N; Johannsson OT; Borg A; Olsson H
Eur J Cancer; 2005 Oct; 41(15):2312-20. PubMed ID: 16118051
[TBL] [Abstract][Full Text] [Related]
33. Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing.
Farshid G; Balleine RL; Cummings M; Waring P;
Am J Surg Pathol; 2006 Nov; 30(11):1357-66. PubMed ID: 17063074
[TBL] [Abstract][Full Text] [Related]
34. Mutations at BRCA1: the medullary breast carcinoma revisited.
Eisinger F; Jacquemier J; Charpin C; Stoppa-Lyonnet D; Bressac-de Paillerets B; Peyrat JP; Longy M; Guinebretière JM; Sauvan R; Noguchi T; Birnbaum D; Sobol H
Cancer Res; 1998 Apr; 58(8):1588-92. PubMed ID: 9563465
[TBL] [Abstract][Full Text] [Related]
35. Estrogens, BRCA1, and breast cancer.
Hilakivi-Clarke L
Cancer Res; 2000 Sep; 60(18):4993-5001. PubMed ID: 11016617
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of BRCA1 gene mutations in patients with early-onset breast cancer and their affected relatives in Guangdong province].
Zhou J; Rao NY; Li SR; Jin L; Jia WJ; Gong C; Yu FY; Su FX; Song EW; Shao ZM
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):213-6. PubMed ID: 19246281
[TBL] [Abstract][Full Text] [Related]
37. Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population.
Wong ES; Shekar S; Chan CH; Hong LZ; Poon SY; Silla T; Lin C; Kumar V; Davila S; Voorhoeve M; Thike AA; Ho GH; Yap YS; Tan PH; Tan MH; Ang P; Lee AS
PLoS One; 2015; 10(7):e0134408. PubMed ID: 26221963
[TBL] [Abstract][Full Text] [Related]
38. Hereditary premenopausal breast cancer.
Strobel ES; Fritschka E
Onkologie; 2002 Feb; 25(1):24-7. PubMed ID: 11893879
[TBL] [Abstract][Full Text] [Related]
39. Novel indications for BRCA1 screening using individual clinical and morphological features.
Eisinger F; Noguès C; Guinebretière JM; Peyrat JP; Bardou VJ; Noguchi T; Vennin P; Sauvan R; Lidereau R; Birnbaum D; Jacquemier J; Sobol H
Int J Cancer; 1999 Jun; 84(3):263-7. PubMed ID: 10371344
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers.
Tung N; Miron A; Schnitt SJ; Gautam S; Fetten K; Kaplan J; Yassin Y; Buraimoh A; Kim JY; Szász AM; Tian R; Wang ZC; Collins LC; Brock J; Krag K; Legare RD; Sgroi D; Ryan PD; Silver DP; Garber JE; Richardson AL
Breast Cancer Res; 2010; 12(6):R95. PubMed ID: 21080930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
